Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Structure and Regulation of Bacterial Biofilm-Promoting Exopolysaccharide Secretion Systems

Project description

Mechanisms of exopolysaccharide secretion in bacterial biofilms

Although bacteria are single-celled organisms, they frequently collaborate, forming communities called biofilms in which the bacteria stick to each other and to surfaces. A complex extracellular matrix including secreted exopolysaccharides provides both protection and a medium for exchanging intracellular signalling molecules. Pathogenic bacteria can switch between a stationary and a mobile biofilm state, directly influencing whether an infection remains acute or becomes chronic. The ERC-funded BacFilm project aims to decode how intracellular signals determine which genes are activated to produce and secrete specific exopolysaccharides. Using advanced structural biology, genetics and imaging, the project will ultimately enable the design of novel anti-infective therapies or bacteria engineered to overproduce industrially beneficial exopolysaccharides.

Objective

Bacteria are commonly defined as unicellular organisms; however, they constantly exchange substances and information with their confrères and the environment, and can efficiently shelter themselves and achieve homeostasis by building multicellular collaborative macrocolonies called biofilms. Members of these sessile communities can undergo significant functional differentiation and are typically embedded in complex extracellular matrix that secures both mechanical protection and a medium for intercellular exchange. Importantly, the switch between sessile and motile life-styles in pathogenic bacteria can correlate directly with the development of chronic vs. acute infections, whereas extracted bacterial matrix components can find a variety of beneficial biotechnological applications.
Exopolysaccharides (EPS) are a major biofilm matrix component and are typically produced by trans-envelope secretion nanomachines, many of which are controlled at multiple levels by the intracellular second messenger c-di-GMP. Here, we will consolidate our expertise in biofilm formation, cyclic dinucleotide signaling, bacterial secretion and integrative structural biology to decipher EPS secretion system assembly and function in several medically and industrially relevant species. We will use complementary recombinant and in situ structural biology approaches together with established genetic and imaging techniques to decipher the molecular events controlling EPS biogenesis from transcription initiation, interdependent protein folding and cooperative subunit interactions; through secretion system assembly, formation of supramolecular secretory nanoarrays and EPS modifications; to harnessing the biosynthetic processes for the engineering of novel anti-infectives or beneficial EPS superproducers. Over the last years we have spearheaded these studies by unprecedented mechanistic insights into several secretion systems and have demonstrated the feasibility of such an ambitious project.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2023-COG

See all projects funded under this call

Host institution

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Net EU contribution
€ 1 950 000,00
Address
RUE MICHEL ANGE 3
75794 Paris
France
Region
Ile-de-France Ile-de-France Paris
Activity type
Research Organisations
Links
Total cost
€ 1 950 000,00

Beneficiaries (1)